AVENUE THERAPEUTICS INC (ATXI) Forecast, Price Target & Analyst Ratings

NASDAQ:ATXIUS05360L4032

Current stock price

0.42 USD
-0.43 (-50.71%)
At close:
0.3998 USD
-0.02 (-4.81%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for AVENUE THERAPEUTICS INC (ATXI).

Forecast Snapshot

Consensus Price Target

Price Target
$8.16
+ 1,842.86% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
N/A

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$8.16
Upside
+ 1,842.86%
From current price of $0.42 to mean target of $8.16, Based on 7 analyst forecasts
Low
$8.08
Median
$8.16
High
$8.40

Price Target Revisions

1 Month
-33.33%
3 Months
-33.33%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for ATXI. The average price target is 8.16 USD. This implies a price increase of 1842.86% is expected in the next year compared to the current price of 0.42.
The average price target has been revised downward by 33.33% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

ATXI Current Analyst RatingATXI Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

ATXI Historical Analyst RatingsATXI Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
ATXI was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ATXI.
In the previous month the buy percentage consensus was at a similar level.
ATXI was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2023-12-11Maxim GroupInitiate Buy
2023-04-03Aegis CapitalInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
N/A

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
43.00%

Next Earnings Summary

Full Analyst Estimates 2024 - 2026

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Revenue
YoY % growth
ATXI revenue by date.ATXI revenue by date.
N/AN/AN/A
EBITDA
YoY % growth
ATXI ebitda by date.ATXI ebitda by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
ATXI ebit by date.ATXI ebit by date.
-4.843M-2.377M
50.92%
-11.421M
-380.48%
-21.816M
-91.02%
-26.265M
-20.39%
-5.213M
80.15%
-3.738M
28.29%
-8.043M
-115.17%
-14.54M
-80.78%
N/A
13.81%
N/A
-15.54%
N/A
-18.11%
Operating Margin
ATXI operating margin by date.ATXI operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ATXI eps by date.ATXI eps by date.
N/AN/AN/AN/A-1,935.00
21.93%
-348.75
81.98%
N/AN/A-131.25
19.07%
N/A
95.15%
N/A
68.59%
N/A
6.12%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ATXI Yearly EPS VS EstimatesATXI Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2022 2023 2024 2025 2026 -500 -1K -1.5K -2K

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
25.69%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

AVENUE THERAPEUTICS INC / ATXI Forecast FAQ

What is the average price target for AVENUE THERAPEUTICS INC (ATXI) stock?

7 analysts have analysed ATXI and the average price target is 8.16 USD. This implies a price increase of 1842.86% is expected in the next year compared to the current price of 0.42.

What is the consensus rating for AVENUE THERAPEUTICS INC (ATXI) stock?

The consensus rating for AVENUE THERAPEUTICS INC (ATXI) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.